# Mariana Brandão

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mariana-brandao/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,654 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 23 |
| i10-index | 42 |
| Last Known Institution | Université Libre de Bruxelles |
| OpenAlex ID | https://openalex.org/A5004669734 |
| ORCID iD | 0000-0002-1653-3544 |
| Works | 159 |

## Researcher papers

- [Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative](https://scholariq.org/papers/genomic-and-transcriptomic-analyses-of-breast-cancer-primaries-and-matched/)
- [Treatment of advanced HER2-positive breast cancer: 2018 and beyond](https://scholariq.org/papers/treatment-of-advanced-her2-positive-breast-cancer-2018-and-beyond/)
- [Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors](https://scholariq.org/papers/biomarkers-of-response-and-resistance-to-pi3k-inhibitors-in-estrogen-receptor/)
- [Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis](https://scholariq.org/papers/impact-of-solid-cancer-on-in-hospital-mortality-overall-and-among-different/)
- [Mammaprint™: a comprehensive review](https://scholariq.org/papers/mammaprinttm-a-comprehensive-review/)
- [What Is the Real Impact of Estrogen Receptor Status on the Prognosis and Treatment of HER2-Positive Early Breast Cancer?](https://scholariq.org/papers/what-is-the-real-impact-of-estrogen-receptor-status-on-the-prognosis-and/)
- [VISTA: A Promising Target for Cancer Immunotherapy?](https://scholariq.org/papers/vista-a-promising-target-for-cancer-immunotherapy/)
- [An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer](https://scholariq.org/papers/an-international-and-multidisciplinary-eortc-survey-on-resectability-of-stage/)
- [Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy](https://scholariq.org/papers/clinical-implications-of-body-mass-index-in-metastatic-breast-cancer-patients/)
- [Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects](https://scholariq.org/papers/combination-therapies-for-the-treatment-of-her2-positive-breast-cancer-current/)
- [Cervical cancer screening uptake in women aged between 15 and 64 years in Mozambique](https://scholariq.org/papers/cervical-cancer-screening-uptake-in-women-aged-between-15-and-64-years-in/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Researcher university

- [Université Libre de Bruxelles](https://scholariq.org/institutions/universite-libre-de-bruxelles/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.